Patient Satisfaction and Visual Performance in Patients with Ocular Pathology after Bilateral Implantation of a New Extended Depth of Focus Intraocular Lens. (28th April 2022)

• Record Type: Journal Article
• Authors: Rementería-Capelo, Laureano A.; Lorente, Pilar; Carrillo, Virginia; Sánchez-Pina, José M.; Ruiz-Alcocer, Javier; Contreras, Inés
• Other Names: García-Lázaro Santiago Academic Editor.
• Is Part Of: Journal of ophthalmology. Volume 2022(2022)
• Publication Date: 2022-04-28
• Subjects: Ophthalmology -- Periodicals; Eye Diseases; Ophthalmology; Ophthalmology; Electronic journals; Periodicals; Periodicals; Fulltext; Internet Resources; Periodicals; 617.7
• DOI: 10.1155/2022/4659309
• Languages: English
• ISSNs: 2090-004X

Abstract

Abstract : Aim . To evaluate visual results and patient-perceived outcomes in patients with ocular pathologies implanted with a new extended depth-of-focus intraocular lens (IOL). Methods . Patients with ocular pathology undergoing cataract surgery and bilaterally implanted with Vivity® IOLs were evaluated three months after surgery. The control group included patients with no ocular pathologies. Binocular defocus curves, corrected and uncorrected mono- and binocular distance visual acuity (DVA), and binocular contrast sensitivity were measured. Patients completed the Catquest-9SF questionnaire and reported on dysphotopsia and their need for spectacle-correction. Results . Twenty-five patients were included in each group. Monocular uncorrected DVA was better in the control group (−0.01 ± 0.07) compared with the study group (0.03 ± 0.08), p = 0.027 . There were no other statistically significant differences in DVA, with an uncorrected binocular acuity of −0.06 ± 0.06 for the control group and −0.05 ± 0.06 for the study group. Binocular defocus curves were similar for both groups and there were no differences in contrast sensitivity values. Pooling the refractive results, 96% of eyes were within ±0.50 D of target refraction. Seventy percent of patients in the control group reported no halos, compared with 40% in the study group, p = 0.047 . In both groups, 40% of patients reported being completely spectacle-independent, with the other 60% requiring glasses for near vision always or often. All patients reported being fairly or very satisfied with their vision. Conclusion . Initial results of visual function after Vivity implantation in patients with ocular pathologies are encouraging, with high patient satisfaction and few difficulties for daily activities.